Acorda Therapeutics Inc PEG
Cos'è PEG di Acorda Therapeutics Inc?
PEG di Acorda Therapeutics Inc è N/A
Qual è la definizione di PEG?
Il rapporto prezzo / utili alla crescita (PEG) è il rapporto P / E di un titolo diviso per il tasso di crescita previsto dei suoi guadagni per un periodo di tempo di 5 anni.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG di aziende nel Health Care settore su NASDAQ rispetto a Acorda Therapeutics Inc
Cosa fa Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Aziende con peg simili a Acorda Therapeutics Inc
- Mallinckrodt Plc ha PEG di N/A
- HighPoint Resources Corp ha PEG di N/A
- Adamas Pharmaceuticals Inc ha PEG di N/A
- Pivot Technology Solutions ha PEG di N/A
- Copper Mountain Mining ha PEG di N/A
- SITO Mobile ha PEG di N/A
- Acorda Therapeutics Inc ha PEG di N/A
- RumbleON Inc ha PEG di N/A
- Endologix ha PEG di N/A
- Alto Ingredients Inc ha PEG di N/A
- Sunesis Pharmaceuticals Inc ha PEG di N/A
- Unit ha PEG di N/A
- Pacific Drilling SA ha PEG di N/A